Here, we present a protocol to provide an ideal minimally invasive surgical approach for the pancreatic head in treating benign, borderline, and low-grade malignant pancreatic tumors as well as chronic pancreatitis.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
* These authors contributed equally
Here, we present a protocol to provide an ideal minimally invasive surgical approach for the pancreatic head in treating benign, borderline, and low-grade malignant pancreatic tumors as well as chronic pancreatitis.
Surgical intervention has demonstrated established efficacy for benign, borderline, and low-grade malignant tumors of the pancreatic head, as well as for chronic pancreatitis. While conventional surgical approaches are associated with significant trauma and considerable loss of digestive function, the current focus in managing these conditions has shifted toward preserving functional organs through minimally invasive techniques. Through an in-depth understanding of the peripancreatic vascular arches, our team has modified the classic Beger procedure to achieve complete en bloc resection of pancreatic head tissue. By leveraging 3D laparoscopic technology, we have successfully integrated the advantages of minimal invasiveness and precise resection. This refined technique preserves duodenal and biliary integrity while ensuring complete removal of pancreatic head tissue, effectively reducing surgical complications, minimizing operative trauma, and decreasing postoperative gastrointestinal dysfunction. Consequently, patient outcomes are substantially improved. This article aims to elucidate the key technical details of this procedure, enabling more surgeons to master and enhance its success rate, thereby providing better treatment options for eligible patients.
Chronic pancreatitis (CP) and benign, borderline, or low-grade malignant tumors of the pancreatic head often impose significant suffering and health risks on patients1. Surgical intervention plays a crucial role in the comprehensive management of chronic pancreatitis and pancreatic head tumors of these types2,3,4. Its objectives include pain relief, improvement of pancreatic function, management of complications, and curative resection of tumors, representing the most effective treatment strategy currently available5.
Access restricted. Please log in or start a trial to view this content.
This surgical approach has received approval from the Ethics Committee of Chongqing General Hospital, Chongqing University. All patients undergoing this procedure provided written informed consent.
1. Exclusion and inclusion criteria
Access restricted. Please log in or start a trial to view this content.
Between December 2023 and April 2025, our surgical team performed 3D laparoscopy-assisted DCOPPHTR on 8 patients. All cases involved benign or low-grade malignant tumors. Two patients had postoperative follow-up durations of less than 3 months, while the remaining 6 patients were followed for over 3 months. The baseline characteristics of these 6 patients are presented in Table 1. The cohort included pancreatic NETs, SPNs, and IPMNs.
All patients successfully underwent the pro.......
Access restricted. Please log in or start a trial to view this content.
The cornerstone of this procedure's success is the preservation of the pancreaticoduodenal vascular arcades. Compromise of these arcades can lead to duodenal or CBD ischemia, potentially resulting in severe complications such as duodenal or biliary necrosis, major bile leak, infection, or hemorrhage. While preservation of both anterior and posterior arcades is ideal, it can be technically challenging with large tumors or severe peripancreatic inflammation. A team from West China Hospital noted that anatomical variati.......
Access restricted. Please log in or start a trial to view this content.
The authors declare no conflicts of interest.
We are thankful to our colleagues in the operating room.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 4K-3D NIR/ICG Videoendoscope | KARL STORZ | OTV-S400 | Imaging System |
| Endoscopic Camera Equipment | KARL STORZ | TC304 | Image 1 S 4U-Link High-Definition Connection Main Unit Module |
| Endoscopic Surgical Instruments | Aesculap AG | 20162223321 | Endoscopic Surgical Instruments |
| Esomeprazole Sodium for Injection | AstraZeneca PLC | 86979096001287 | Proton Pump Inhibitor |
| Ethicon Endo-Surgery Generator | Johnson & Johnson | 20153230137 | Provide ultrasound and radiofrequency energy |
| HARMONIC Ultrasonic Scalpel | Johnson & Johnson | HAR1120 | Ultrasonic Energy Cutting |
| HEM-O-LOK Polymer Ligating Clips | WECK | 544230 Medium-Large | Locking ligation system. |
| LED Cold Light Source for Endoscope | KARL STORZ | TL400 | Main Unit of Medical Endoscope Cold Light Source |
| Piperacillin Sodium and Tazobactam Sodium for Injection | Wyeth Piperacillin Div. of Wyeth Holdings Corporation | J20110021 | Broad-spectrum antibiotics |
| Pleated Drainage Tube | Sumitomo Bakelite Akita Co., Ltd | MD-45110 | Surgical Site Drainage |
| Polydioxanone Suture | Ethicon | 29943 | Soft Tissue Suture |
| Somatostatin for Injection | Merck Serono SA Aubonne Branch | 8.69793E+13 | Synthetic Somatostatin Analogues |
Access restricted. Please log in or start a trial to view this content.
This article has been published
Video Coming Soon